Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2009
07/08/2009CN100509790C Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
07/08/2009CN100509788C Neurotensin active 2,3-diaryl-pyrazolidine derivatives
07/08/2009CN100509784C Inhibitors of hepatitis C virus ns3/ns4a serine protease
07/08/2009CN100509782C NK* antagonists
07/08/2009CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase
07/08/2009CN100508980C Compositions for combating lower urinary tract dysfunctions with delta opioid receptor agonists
07/08/2009CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
07/07/2009US7557222 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis
07/07/2009US7557219 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
07/07/2009US7557218 Hydrates of optionally substituted 2-(2-pyridinyl) methylthio-1H-benzimidazoles and process for the production thereof
07/07/2009US7557217 Production of a precipitate of a 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole alkali metal salt by dissolving the compound in a first organic solvent, adding an alkali metal hydroxide, adding second organic solvent to reaction mixture; gastric acid secretion inhibitor
07/07/2009US7557212 Tricyclic derivatives as LTD4 antagonists
07/07/2009US7557210 Antiinflamamtory agents
07/07/2009US7557132 Compounds useful as pesticides
07/07/2009US7557131 Substituted triazole derivatives as oxytocin antagonists
07/07/2009US7557130 Bicyclic heteroaromatic alanines
07/07/2009US7557129 Cyanopyridine derivatives useful in the treatment of cancer and other disorders
07/07/2009US7557127 HDAC inhibitor
07/07/2009US7557125 Fab I inhibitors
07/07/2009US7557123 Heterocyclic compound and medicinal use thereof
07/07/2009US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives
07/07/2009US7557115 Compounds for modulation of kinesins as anticancer agents with administering
07/07/2009US7557107 tricyclic compounds such as 4-{8-Chloro-6-[[(1-methoxy-cyclopropanecarbonyl)-amino]-(3-methyl-3H-imidazol-4- yl)-methyl]-11H-benzo[5.6]cyclohepta[1,2-b]pyridin-11-yl}-piperazine-1-carboxylic acid isopropyl ester, used as enzyme inhibitors for treatment of cancers
07/07/2009US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide
07/07/2009US7557105 Proliferative disorders; cancer; 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
07/07/2009US7557102 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses
07/07/2009CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
07/07/2009CA2461510C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
07/07/2009CA2450033C Viral polymerase inhibitors
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/07/2009CA2378834C Pyrazinones, compositions containing such compounds
07/04/2009CA2648836A1 New derivatives of 1h-indol-1-urea, a process for their preparation and pharmaceutical compositions containing them
07/02/2009WO2009082526A2 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation
07/02/2009WO2009082346A1 New acetyl coenzyme a carboxylase (acc) inhibitors and uses in treatments of obesity and diabetes mellitus - 087
07/02/2009WO2009081789A1 Sulfonyl substituted 6-membered ring derivative
07/02/2009WO2009081782A1 N-pyrazole-2-pyridinecarboxamide derivative
07/02/2009WO2009081579A1 Nitrogen-containing heterocyclic compound and bactericide for agricultural and horticultural use
07/02/2009WO2009081259A1 Phenoxy-pyridyl derivatives
07/02/2009WO2009081195A1 Carbamoyl compounds as dgat1 inhibitors 190
07/02/2009WO2009081105A2 Quinoxaline and quinoline derivatives as kinase inhibitors
07/02/2009WO2009080799A2 Carbazole-based hole transport and /or electron blocking materials and /or host polymer materials
07/02/2009WO2009080555A2 Carboxyl- or hydroxyl- substituted benzimidazole derivatives
07/02/2009WO2009080533A1 Heteroaryl derivatives as orexin receptor antagonists
07/02/2009WO2009080500A1 Process for the preparation of pyrido [2,1-a] isoquinoline derivatives
07/02/2009WO2009080367A2 Specific inhibitors of pteridine reductase with antiparasitic action
07/02/2009WO2009080366A1 A process of making imatinib
07/02/2009WO2009080335A1 Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
07/02/2009WO2009079797A1 Compounds and method for treatment of cancer
07/02/2009WO2009079767A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
07/02/2009WO2009079683A1 Translocator protein ligands
07/02/2009WO2009064836A3 Kynurenine-aminotransferase inhibitors
07/02/2009WO2009049305A3 5- (2-hydroxyphenyl) tetrazoles as hsp90 inhibitors against cancer
07/02/2009WO2009043797A3 Salts of a cgrp antagonist, method for producing the same and use thereof as drugs
07/02/2009WO2009016410A3 Chemical compounds 831
07/02/2009WO2009012375A3 Squarate kinase inhibitors
07/02/2009WO2007109045A8 Heterocyclic organic compounds for the treatment of in particular melanoma
07/02/2009US20090171093 3'-Fluoro-5'-hydroxythalidomide and derivatives thereof
07/02/2009US20090171086 2,4-pyrimidinediamine compounds and their uses
07/02/2009US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
07/02/2009US20090170941 Pharmaceutical Compounds
07/02/2009US20090170922 Benzimidazole derivatives and their use as a medicament
07/02/2009US20090170921 Benzimidazole derivatives
07/02/2009US20090170901 Benzoyl Urea Derivatives
07/02/2009US20090170898 Sulphonamide Derivatives as Modulators of the Glucocorticoid Receptor
07/02/2009US20090170894 Urea derivatives of tropane, their preparation and their therapeutic application
07/02/2009US20090170887 Novel indazole derivative having spiro ring structure in side chain
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170877 5,6-Trimethylenepyrimidin-4-one compounds
07/02/2009US20090170875 Compounds for the treatment of inflammatory disorders
07/02/2009US20090170874 Triazole-substituted arylamides as P2X3 and P2X2/3 antagonists
07/02/2009US20090170873 Pyrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
07/02/2009US20090170872 Compounds and Their Pharmaceutical Use
07/02/2009US20090170868 Trpv1 antagonists including dihydroxy substituent and uses thereof
07/02/2009US20090170867 Trpv1 antagonists including sulfonamide substituent and uses thereof
07/02/2009US20090170859 Viral Polymerase Inhibitors
07/02/2009US20090170854 New Use
07/02/2009US20090170850 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
07/02/2009US20090170838 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
07/02/2009US20090170836 New inhibitors of histone deacetylase
07/02/2009US20090170835 Isoindoline derivatives
07/02/2009US20090170833 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
07/02/2009US20090170832 HETEROCYCLIC COMPOUNDS HAVING TYPE I 11beta HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY
07/02/2009US20090170831 Substituted lactams as inhibitors of abeta protein production
07/02/2009US20090170829 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same
07/02/2009US20090170828 Azetidine Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
07/02/2009US20090170827 Acid Addition Salt of Dihydropyridine Derivative
07/02/2009US20090170826 Acid Addition Salt of Optically Active Dihydropyridine Derivative
07/02/2009US20090170812 Transcription factor modulating compounds and methods of use thereof
07/02/2009US20090167166 Materials for organic electroluminescent devices
07/02/2009US20090166670 Anthracene-based compound and organic light emitting device employing the same
07/02/2009CA2710447A1 Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
07/02/2009CA2710039A1 Compounds and method for treatment of cancer
07/02/2009CA2710016A1 Translocator protein ligands
07/02/2009CA2709536A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer
07/02/2009CA2708372A1 Carboxyl- or hydroxylsubstituted benzimidazole derivatives
07/02/2009CA2708314A1 Process for the preparation of pyrido [2,1-a] isoquinoline derivatives
07/02/2009CA2707660A1 Carbamoyl compounds as dgat1 inhibitors 190
07/02/2009CA2707447A1 Sulfonyl-substituted 6-membered ring derivative
07/02/2009CA2707403A1 N-pyrazole-2-pyridinecarboxamide derivative
07/02/2009CA2705411A1 Heteroaryl derivatives as orexin receptor antagonists